GLPwatch
Trials (2167)
Page 12 of 37.
- A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
- Semaglutide for Alcohol Use Disorder
- Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin
- Exenatide Treatment in Parkinson's Disease
- The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults
- A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
- The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
- Exenatide For Reducing the Reinforcing Effects of Cocaine
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)
- Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients
- Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi
- A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
- Aging Well: Targeting Obesity With GLP-1 Agonists to Enhance Physical and Vascular Health in Postmenopausal Women
- Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
- A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide
- A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden
- Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation
- The Effect of Liraglutide on Endothelial Function in Subjects With Type 2 Diabetes Mellitus
- The Effect of Liraglutide on the GIT
- Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
- Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
- SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial
- Effect of Oral Semaglutide on Liver Fat and Body Composition in Liver Transplant Recipients With Diabetes Mellitus
- Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)
- Prevent and Reverse Obesity in Children, Adolescents and Young Adults
- A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
- A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)
- GLP-1 Receptor Agonists to Decrease Ethanol and CVD Risk in HIV
- Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment
- Preoperative Optimization With Tirzepatide, Ketogenic Diet, or Standard Care Before One Anastomosis Gastric Bypass Surgery
- AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
- Emulation of the REWIND Cardiovascular Outcomes Trial in Healthcare Claims Data.
- A Research Study to Look Into How Well Semaglutide Medicine Works at Different Doses in People With Type 2 Diabetes and Overweight
- "Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."
- A Research Study Looking at Similarity Between LY3437943 Versions for Different Injection Devices
- Salivary Function and Dental Changes During GLP-1 Therapy
- Diabetes Islet Preservation Immune Treatment
- Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide
- Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities
- GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
- The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy
- A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide
- A Clincial Study Testing Tirzepatide on Reproductive Function and Metabolic Health in Women With PCOS Who Are Overweight or Obese
- An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
- Focusing on the Menopausal Transition to Improve Mid-Life Women's Health
- A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in United Kingdom, as Part of Local Clinical Practice (SURE UK)
- Cardiovascular Effects of GLP-1 Receptor Activation
- Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities
- Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes
- Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
- Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity
- Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease
- Semaglutide for Helping Opioid Recovery
- Testosterone Replacement Therapy and Liraglutide Effects on Weight Loss in Hypogonadism.
- First Research Study to Look at How Two Medicines, NNC0480-0389 and Semaglutide, Work Together in Healthy People, in People With High Body Weight and in People With Diabetes
- A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
- Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes
- Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.